J
Juan V. Llau
Researcher at University of Valencia
Publications - 89
Citations - 4059
Juan V. Llau is an academic researcher from University of Valencia. The author has contributed to research in topics: Perioperative & Dabigatran. The author has an hindex of 25, co-authored 83 publications receiving 3615 citations.
Papers
More filters
Journal ArticleDOI
Management of severe perioperative bleeding Guidelines from the European Society of Anaesthesiology
Sibylle A. Kozek-Langenecker,Arash Afshari,Pierre Albaladejo,Cesar Aldecoa Alvarez Santullano,Edoardo De Robertis,Daniela Filipescu,Dietmar Fries,Thorsten Haas,Georgina Imberger,Matthias Jacob,Marcus D. Lancé,Juan V. Llau,Susan Mallett,Jens Meier,Niels Rahe-Meyer,Charles Marc Samama,Andrew Smith,Cristina Solomon,Philippe Van der Linden,Anne Wikkelsø,Patrick Wouters,Piet Wyffels +21 more
TL;DR: These guidelines are intended to provide an overview of current knowledge on the subject with an assessment of the quality of the evidence in order to allow anaesthetists throughout Europe to integrate this knowledge into daily patient care wherever possible.
Journal ArticleDOI
Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology.
Wiebke Gogarten,Erik Vandermeulen,Hugo Van Aken,Sibylle Kozek,Juan V. Llau,Charles Marc Samama +5 more
TL;DR: In this article, the authors proposed a strict adherence to the recommended time intervals between the administration of anticoagulants, neuraxial blockade and the re-construction of the spinal epidural haematoma.
Regional anaesthesia and antithrombotic agents: Recommendations of the european society of anaesthesiology
TL;DR: Regional anaesthesia in patients receiving full anticoagulation treatment continues to be contraindicated and care should be taken to avoid traumatic puncture during regional anaesthetic techniques.
Journal ArticleDOI
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Gilles Pernod,P. Albaladejo,Anne Godier,Charles Marc Samama,Sophie Susen,Yves Gruel,Normand Blais,Pierre Fontana,Ariel Cohen,Juan V. Llau,Nadia Rosencher,Jean-François Schved,Emmanuel de Maistre,Meyer Michel Samama,Patrick Mismetti,Pierre Sié +15 more
TL;DR: For urgent surgery with haemorrhagic risk, the drug plasma concentration should be less or equal to 30ng/mL for dabigatran and rivaroxaban and the administration of a procoagulant drug is discussed according to the NOAC concentration and the possibilities of mechanical haemostasis.
Journal ArticleDOI
Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: thrombin or factor-Xa inhibitors. Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis.
Pierre Sié,Charles Marc Samama,A. Godier,Nadia Rosencher,Annick Steib,Juan V. Llau,Philippe Van der Linden,Gilles Pernod,Thomas Lecompte,Isabelle Gouin-Thibault,Pierre Albaladejo +10 more
TL;DR: Direct oral anticoagulants--inhibitors of thrombin or factor-Xa--are expected to replace vitamin K antagonists in most of their indications and perioperative management for optimal safety regarding the risk of bleeding and thrombosis is proposed.